ALXN
Alexion Pharmaceuticals
ALXN
ALXN
Delisted
ALXN was delisted on the 20th of July, 2021.
596 hedge funds and large institutions have $23.4B invested in Alexion Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 81 funds opening new positions, 219 increasing their positions, 225 reducing their positions, and 63 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
6% less funds holding in top 10
Funds holding in top 10: 17 → 16 (-1)
7% less capital invested
Capital invested by funds: $25.3B → $23.4B (-$1.85B)
Holders
596
Holding in Top 10
16
Calls
$468M
Puts
$434M
Top Buyers
| 1 | +$275M | |
| 2 | +$180M | |
| 3 | +$134M | |
| 4 |
MWNA
Marshall Wace North America
New York
|
+$110M |
| 5 |
Millennium Management
New York
|
+$99.7M |
Top Sellers
| 1 | -$193M | |
| 2 | -$187M | |
| 3 | -$144M | |
| 4 |
Sands Capital Management
Arlington,
Virginia
|
-$124M |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$107M |